Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
Authors
Keywords
Colorectal cancer, Negative staining, Histology, Immunohistochemistry techniques, Radical surgery, Adjuvant chemotherapy, Lymph nodes, Surgical oncology
Journal
PLoS One
Volume 12, Issue 9, Pages e0185436
Publisher
Public Library of Science (PLoS)
Online
2017-09-28
DOI
10.1371/journal.pone.0185436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ezrin Is Associated with Disease Progression in Ovarian Carcinoma
- (2016) Vered Horwitz et al. PLoS One
- Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
- (2015) T T Seppälä et al. BRITISH JOURNAL OF CANCER
- Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma
- (2015) Jinru Shia SEMINARS IN DIAGNOSTIC PATHOLOGY
- Adjuvant Chemotherapy for Stage II Right-Sided and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data
- (2014) Jennifer M. Weiss et al. ANNALS OF SURGICAL ONCOLOGY
- Predictors of recurrence free survival for patients with stage II and III colon cancer
- (2014) Vassiliki L Tsikitis et al. BMC CANCER
- Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
- (2013) Vlad Popovici et al. BMC CANCER
- Colon and Rectal Cancer Survival by Tumor Location and Microsatellite Instability
- (2013) Amanda I. Phipps et al. DISEASES OF THE COLON & RECTUM
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
- (2013) Paul Lochhead et al. JNCI-Journal of the National Cancer Institute
- Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types
- (2013) Inti Zlobec et al. Journal of Translational Medicine
- Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series
- (2012) M. A. Merok et al. ANNALS OF ONCOLOGY
- Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells
- (2012) Vicky Goler-Baron et al. BIOCHEMICAL PHARMACOLOGY
- BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
- (2012) A. I. Phipps et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value
- (2012) P. G. Gavin et al. CLINICAL CANCER RESEARCH
- Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
- (2012) William K. Funkhouser et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Activation of AMP-activated Protein Kinase Is Essential for Lysophosphatidic Acid-induced Cell Migration in Ovarian Cancer Cells
- (2011) Eung-Kyun Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-risk stage II colon cancer after curative resection
- (2011) Harunobu Sato et al. JOURNAL OF SURGICAL ONCOLOGY
- Challenges in the Management of Stage II Colon Cancer
- (2011) Efrat Dotan et al. SEMINARS IN ONCOLOGY
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer☆
- (2010) Eija A. Korkeila et al. HUMAN PATHOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Relevance of Microsatellite Instability in Colorectal Cancer
- (2010) Albert de la Chapelle et al. JOURNAL OF CLINICAL ONCOLOGY
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
- Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer
- (2008) Adam Elzagheid et al. HUMAN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More